Elevance Health, Inc. (ELV)
(Delayed Data from NYSE)
$537.26 USD
-2.42 (-0.45%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $537.26 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Price, Consensus and EPS Surprise
ELV 537.26 -2.42(-0.45%)
Will ELV be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ELV based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ELV
HCA Healthcare's (HCA) Q1 Earnings Beat on Rising Admissions
Here's Why Elevance Health (ELV) is a Strong Momentum Stock
ELV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Elevance Health (ELV) is a Strong Momentum Stock
Zacks Industry Outlook Highlights Elevance Health Medpace and Doximity
Community Health (CYH) Q1 Earnings Top on Better Occupancy Rates
Other News for ELV
Elevance Health Inc EVP & President, Gov Health Felicia Norwood Sells 20,310 Shares
Top 4 Health Care Stocks That May Plunge This Month
Here's How Much You Would Have Made Owning Elevance Health Stock In The Last 5 Years
Looking Into Elevance Health's Recent Short Interest
Polaris Global Equity Composite Q1 2024 Commentary